Live Breaking News & Updates on Nasdaq Bcli

Stay updated with breaking news from Nasdaq bcli. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Short Interest Update

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI – Get Free Report) was the recipient of a significant increase in short interest in April. As of April 15th, there was short interest totalling 1,990,000 shares, an increase of 48.5% from the March 31st total of 1,340,000 shares. Based on an average daily volume of 987,100 shares, the short-interest […] ....

Securities Exchange Commission , Brainstorm Cell Therapeutics Inc , Kingswood Wealth Advisors , Brainstorm Cell Therapeutics , Get Free Report , Cell Therapeutics , Brainstorm Cell , Wealth Advisors , Free Report , Cell Therapeutics Inc , Brainstorm Cell Therapeutics Daily , Nasdaq Bcli ,

Head-To-Head Analysis: Brainstorm Cell Therapeutics (NASDAQ:BCLI) and Tenaya Therapeutics (NASDAQ:TNYA)

Brainstorm Cell Therapeutics (NASDAQ:BCLI – Get Free Report) and Tenaya Therapeutics (NASDAQ:TNYA – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, dividends, risk, profitability and institutional ownership. Institutional & Insider Ownership 21.0% of […] ....

South San Francisco , United States , New York , Golden Hand Resources Inc , Brainstorm Cell Therapeutics Inc , Tenaya Therapeutics Inc , Brainstorm Cell Therapeutics , Get Free Report , Tenaya Therapeutics , Cell Therapeutics , Tenaya Therapeutic , Given Brainstorm Cell Therapeutic , Cell Therapeutics Inc , Golden Hand Resources , Brainstorm Cell Therapeutics Daily , Nasdaq Bcli , Stock Comparison , Stock Analysis ,

Brainstorm Cell Therapeutics (NASDAQ:BCLI) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Free Report) in a research note published on Wednesday morning. The firm issued a hold rating on the biotechnology company’s stock. Brainstorm Cell Therapeutics Stock Performance Shares of NASDAQ:BCLI opened at $0.39 on Wednesday. Brainstorm Cell Therapeutics has a one year low of $0.13 […] ....

Virtu Financial , Jpmorgan Chase Co , Brainstorm Cell Therapeutics Company Profile , Renaissance Technologies , Brainstorm Cell Therapeutics Inc , Brainstorm Cell Therapeutics , Free Report , Cell Therapeutics , Get Free Report , Brainstorm Cell , Street Corp , Jane Street Group , Cell Therapeutics Inc , Brainstorm Cell Therapeutics Daily , Nasdaq Bcli , Initiated Coverage , Stocknews Com ,

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Short Interest Update

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI – Get Free Report) saw a significant decline in short interest in the month of January. As of January 15th, there was short interest totalling 2,390,000 shares, a decline of 43.2% from the December 31st total of 4,210,000 shares. Based on an average trading volume of 2,600,000 shares, the days-to-cover […] ....

Virtu Financial , Brainstorm Cell Therapeutics Inc , Renaissance Technologies , Maxim Group , Wells Fargo Company , Marshall Wace , Brainstorm Cell Therapeutics , Get Free Report , Brainstorm Cell , Cell Therapeutics , Cell Therapeutics Inc , Brainstorm Cell Therapeutics Daily , Nasdaq Bcli ,

Brainstorm Cell Therapeutics (NASDAQ:BCLI) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Free Report) in a research note issued to investors on Tuesday. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, Maxim Group lowered Brainstorm Cell Therapeutics from a buy rating to a hold rating in a research report on Thursday, September […] ....

Renaissance Technologies , Brainstorm Cell Therapeutics Inc , Blackrock Inc , Jpmorgan Chase Co , Pricet Rowe Associates Inc , Maxim Group , Brainstorm Cell Therapeutics , Free Report , Cell Therapeutics Stock Down , Cell Therapeutics , Get Free Report , Pricet Rowe Associates , Cell Therapeutics Inc , Brainstorm Cell Therapeutics Daily , Nasdaq Bcli , Initiated Coverage , Stocknews Com ,